Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-08-10 Purchase |
2023-08-16 6:01 pm |
Indaptus Therapeutics Inc. | INDP | Anderson Glen R. 10% Owner |
103,352 | $2.0937 | $216,388 | 1,190,400 (Indirect) |
View |
2022-01-31 Purchase |
2022-12-19 9:06 pm |
Indaptus Therapeutics Inc. | INDP | Litchev Boyan Vesselinov Chief Medical Officer |
1,150 | $2.1914 | $2,520 | 1,150 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-25 Option Award |
2024-11-26 4:12 pm |
N/A 2029-11-25 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
42,553 | $1.175 | 245,412 (Direct) |
View |
2024-10-09 Option Award |
2024-10-10 4:05 pm |
N/A 2034-10-09 |
Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner |
75,000 | $0 | 75,000 (Direct) |
View |
2024-10-09 Option Award |
2024-10-10 4:05 pm |
N/A 2034-10-09 |
Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2024-10-09 Option Award |
2024-10-10 4:05 pm |
N/A 2034-10-09 |
Indaptus Therapeutics Inc. | INDP | Waltzman Roger J. Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2024-10-09 Option Award |
2024-10-10 4:05 pm |
N/A 2034-10-09 |
Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Operating Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2024-10-09 Option Award |
2024-10-10 4:05 pm |
N/A 2034-10-09 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
75,000 | $0 | 75,000 (Direct) |
View |
2024-08-08 Option Award |
2024-08-08 5:30 pm |
N/A 2029-08-08 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
84,932 | $1.825 | 245,238 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
Indaptus Therapeutics Inc. | INDP | Karah Hila Director |
12,500 | $0 | 12,500 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director |
12,500 | $0 | 12,500 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
Indaptus Therapeutics Inc. | INDP | Pomerantz Roger Director |
30,000 | $0 | 30,000 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
Indaptus Therapeutics Inc. | INDP | MADDALUNA ANTHONY J Director |
12,500 | $0 | 12,500 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
Indaptus Therapeutics Inc. | INDP | Martell Robert Director |
12,500 | $0 | 12,500 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 5:00 pm |
N/A 2034-06-06 |
Indaptus Therapeutics Inc. | INDP | Hayes William B Director |
12,500 | $0 | 12,500 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:15 pm |
N/A 2034-01-22 |
Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Operating Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:15 pm |
N/A 2034-01-22 |
Indaptus Therapeutics Inc. | INDP | Waltzman Roger J. Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:15 pm |
N/A 2034-01-22 |
Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:15 pm |
N/A 2034-01-22 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
100,000 | $0 | 100,000 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:15 pm |
N/A 2034-01-22 |
Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner |
43,250 | $0 | 43,250 (Direct) |
View |
2023-08-07 Option Award |
2023-08-07 5:25 pm |
N/A 2033-08-07 |
Indaptus Therapeutics Inc. | INDP | Waltzman Roger J. Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2023-05-25 Option Award |
2023-05-30 4:15 pm |
N/A 2033-05-25 |
Indaptus Therapeutics Inc. | INDP | Karah Hila Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-05-25 Option Award |
2023-05-30 4:15 pm |
N/A 2033-05-25 |
Indaptus Therapeutics Inc. | INDP | Hayes William B Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-05-25 Option Award |
2023-05-30 4:15 pm |
N/A 2033-05-25 |
Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-05-25 Option Award |
2023-05-30 4:15 pm |
N/A 2033-05-25 |
Indaptus Therapeutics Inc. | INDP | Pomerantz Roger Director |
30,000 | $0 | 30,000 (Direct) |
View |
2023-05-25 Option Award |
2023-05-30 4:15 pm |
N/A 2033-05-25 |
Indaptus Therapeutics Inc. | INDP | MADDALUNA ANTHONY J Director |
12,500 | $0 | 12,500 (Direct) |
View |
2023-02-13 Option Award |
2023-02-14 5:58 pm |
N/A 2033-02-13 |
Indaptus Therapeutics Inc. | INDP | Martell Robert Director |
20,000 | $0 | 20,000 (Direct) |
View |
2023-01-18 Option Award |
2023-01-20 4:05 pm |
N/A 2033-01-18 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
100,000 | $0 | 100,000 (Direct) |
View |
2023-01-18 Option Award |
2023-01-20 4:05 pm |
N/A 2033-01-18 |
Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer |
40,000 | $0 | 40,000 (Direct) |
View |
2023-01-18 Option Award |
2023-01-20 4:05 pm |
N/A 2033-01-18 |
Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
2023-01-18 Option Award |
2023-01-20 4:05 pm |
N/A 2033-01-18 |
Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner |
43,250 | $0 | 43,250 (Direct) |
View |